Armata Pharmaceuticals (ARMP) Net Cash Flow Growth (1y) (2014 - 2026)
Armata Pharmaceuticals (ARMP) Net Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.46 Bn | 470.67 Bn | 1.35 Bn | 301.06% |
| 5 | Vertex Pharmaceuticals | 123.19 Bn | 115.94 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 69.44 Bn | 60.69 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - | - |
| 8 | Argenx Se | 57.08 Bn | 51.90 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.11 Bn | 38.11 Bn | - | - |
| 10 | Armata Pharmaceuticals | 168.22 Mn | 163.42 Mn | - | -325.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -325.57% |
| Dec 31, 2025 | 22.70% |
| Sep 30, 2025 | 212.56% |
| Jun 30, 2025 | 35.75% |
| Mar 31, 2025 | -90.43% |
| Dec 31, 2024 | 25.51% |
| Sep 30, 2024 | -179.82% |
| Jun 30, 2024 | 9.45% |
| Mar 31, 2024 | 140.63% |
| Dec 31, 2023 | -0.09% |
| Sep 30, 2023 | 200.09% |
| Jun 30, 2023 | -34.15% |
| Mar 31, 2023 | -75.50% |
| Dec 31, 2022 | -488.93% |
| Sep 30, 2022 | -112.38% |
| Jun 30, 2022 | -91.71% |
| Mar 31, 2022 | 219.23% |
| Dec 31, 2021 | 71.33% |
| Sep 30, 2021 | -39.96% |
| Jun 30, 2021 | -28.67% |